Eradicating cancer with immune cells armed with nanorings

June 29, 2018, University of Minnesota
(L-R) Dr. Carston R. Wagner with his students, Jacob Petersburg and Cliff Csizmar, at the Wagner Research Lab. Credit: University of Minnesota

Can we use nanotechnology to transform our own immune cells into cancer serial killers?

Dr. Carston R. Wagner, professor and endowed chair of the Department of Medicinal Chemistry in the College of Pharmacy and Masonic Cancer Center member, has proven so by his team's development of techniques that activate , specifically T-cells, to track down and eradicate . This research, published in ACS Nano, highlights one of the most exciting areas in .

The College of Pharmacy's Wagner Research Lab developed a method for rapidly functionalizing T-cell surfaces without the need for genetic engineering. The study demonstrated the ability to safely eradicate solid tumors in mice. Furthermore, the research exhibited effectiveness against breast cancer, the most common form of cancer among women.

"We designed protein-based nanorings that bind to T-cells," explained Wagner. "The modified T-cells—called Prosthetic Antigen Receptors (PAR-T)—quickly and continuously destroy upon finding them."

The researchers demonstrated that they can use the Food and Drug Administration (FDA) approved drug Trimethoprim to switch the nanorings off to help address potential toxic side effects that can arise with immune cell-based anticancer therapies.

"With some luck, using the tools of chemical biology and nanotechnology, we may be able to expand the scope of for the treatment of some of the toughest cancers we face," stated Wagner.

Wagner and his fellow researchers are currently working on targeting , which is key to stopping cancer from recurring. Preliminary studies have shown that a PAR-T cell approach can work in this arena, too. In the hope of moving their discoveries into the clinic, the U of M recently licensed the technology to Tychon Bioscience, LLC., a local start-up company, where Wagner is a founder and Chief Scientific Officer.

Explore further: Researchers discover new approach to stimulate an immune response against tumor cells

More information: Jacob R. Petersburg et al. Eradication of Established Tumors by Chemically Self-Assembled Nanoring Labeled T Cells, ACS Nano (2018). DOI: 10.1021/acsnano.8b01308

Related Stories

Scientists isolate cancer stem cells using novel method

February 22, 2018

Researchers at The University of Texas at Dallas have devised a new technique to isolate aggressive cells thought to form the root of many hard-to-treat metastasized cancers—a significant step toward developing new drugs ...

Stem cell vaccine immunizes lab mice against multiple cancers

February 15, 2018

Stanford University researchers report that injecting mice with inactivated induced pluripotent stem cells (iPSCs) launched a strong immune response against breast, lung, and skin cancers. The vaccine also prevented relapses ...

Recommended for you

Stealth-cap technology for light-emitting nanoparticles

November 14, 2018

A team of scientists from the Helmholtz-Zentrum Dresden-Rossendorf (HZDR), in collaboration with researchers from Monash University Australia, has succeeded in significantly increasing the stability and biocompatibility of ...

Detecting light in a different dimension

November 13, 2018

Scientists from the Center for Functional Nanomaterials (CFN)—a U.S. Department of Energy (DOE) Office of Science User Facility at Brookhaven National Laboratory—have dramatically improved the response of graphene to ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.